The immunogenicity of the U.K. group B meningococcal vaccine (4CMenB) schedule against group B and C meningococcal strains: outcomes of the Sched3 randomised clinical trial.
Davis K., Valente Pinto M., Andrews N., Goldblatt D., Borrow R., Findlow H., Southern J., PARTINGTON J., PLESTED E., Patel S., Holland A., Matheson M., England A., Hallis B., Miller E., SNAPE M.